35740-85-3

Basic information

• Product Name: 3-(bromomethyl)quinolin-2(1H)-one
• CAS NO: 35740-85-3
• Molecular Formula: C₁₀H₈BrNO
• Molecular Weight: 238.0806
• Mol File: 35740-85-3.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 391.8°C at 760 mmHg
• Flash Point: 190.8°C
• Density: 1.542g/cm³
• Vapor Pressure: 2.4E-06mmHg at 25°C
• Refractive Index: 1.616
• CAS DataBase Reference: 3-(bromomethyl)quinolin-2(1H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(bromomethyl)quinolin-2(1H)-one(35740-85-3)
• EPA Substance Registry System: 3-(bromomethyl)quinolin-2(1H)-one(35740-85-3)

Safety Data

• Hazardous Substances Data: 35740-85-3(Hazardous Substances Data)

Upstream product

• 73568-25-9 2-chloro-3-quinoline carboxaldehyde 
• 90097-45-3 3-(hydroxymethyl)-(1H)-quinol-2-one 
• 91301-03-0 3-formyl-2-quinolone 
• 114561-16-9 3-bromomethyl-1-methyl-2-oxo-1,2-dihydroquinoline 
• 125917-60-4 2-chloro-3-(hydroxymethyl)quinoline 

Downstream Products

• 90097-99-7 2-Benzoylamino-3-(2-oxo-1,2-dihydro-quinolin-3-yl)-propionic acid 
• 90097-98-6 2-(Cyclohexanecarbonyl-amino)-3-(2-oxo-1,2-dihydro-quinolin-3-yl)-propionic acid 
• 103702-31-4 2-(4-chlorobenzoylamino)-3-(2-quinolon-3-yl)propionic acid 
• 133739-04-5 3-[3-Fluoro-5-(4-methoxy-tetrahydro-pyran-4-yl)-phenoxymethyl]-1H-quinolin-2-one 

Relevant articles and documents

HETEROCYCLIC ETHERS

The invention concerns a heterocyclic ether of the formula I wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (l-6C)alkylene, (3-6C)alkenylene, (3-6C)alkyny

Carbostyril derivatives

Disclosed are carbostyril derivatives and their salts of the formulas STR1 The compounds have anti-peptic ulcer effects, and are useful as a treating agent for curing peptic ulcers in the digestive system, such as ulcers in the stomach and in the duodenum. The compounds particularly have prophylaxis and curing effects for treating chronic ulcers, for example experimental acetic acid-induced ulcers and cautery ulcers, with both low toxicity and few side-effects. Also disclosed are processes for preparing the compounds and for preparing pharmaceutical compositions containing them.